Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia-a randomized controlled feeding trial
BACKGROUND: Carbohydrate restriction shows promise for diabetes, but concerns regarding high saturated fat content of low-carbohydrate diets limit widespread adoption. OBJECTIVES: This preplanned ancillary study aimed to determine how diets varying widely in carbohydrate and saturated fat affect car...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
LEADER | 04778nam a2200865Ia 4500 | ||
---|---|---|---|
001 | 10-1093-ajcn-nqab287 | ||
008 | 220420s2022 CNT 000 0 und d | ||
020 | |a 19383207 (ISSN) | ||
245 | 1 | 0 | |a Effects of a low-carbohydrate diet on insulin-resistant dyslipoproteinemia-a randomized controlled feeding trial |
260 | 0 | |b NLM (Medline) |c 2022 | |
300 | |a 9 | ||
856 | |z View Fulltext in Publisher |u https://doi.org/10.1093/ajcn/nqab287 | ||
520 | 3 | |a BACKGROUND: Carbohydrate restriction shows promise for diabetes, but concerns regarding high saturated fat content of low-carbohydrate diets limit widespread adoption. OBJECTIVES: This preplanned ancillary study aimed to determine how diets varying widely in carbohydrate and saturated fat affect cardiovascular disease (CVD) risk factors during weight-loss maintenance. METHODS: After 10-14% weight loss on a run-in diet, 164 participants (70% female; BMI = 32.4 ± 4.8 kg/m2) were randomly assigned to 3 weight-loss maintenance diets for 20 wk. The prepared diets contained 20% protein and differed 3-fold in carbohydrate (Carb) and saturated fat as a proportion of energy (Low-Carb: 20% carbohydrate, 21% saturated fat; Moderate-Carb: 40%, 14%; High-Carb: 60%, 7%). Fasting plasma samples were collected prerandomization and at 20 wk. Lipoprotein insulin resistance (LPIR) score was calculated from triglyceride-rich, high-density, and low-density lipoprotein particle (TRL-P, HDL-P, LDL-P) sizes and subfraction concentrations (large/very large TRL-P, large HDL-P, small LDL-P). Other outcomes included lipoprotein(a), triglycerides, HDL cholesterol, LDL cholesterol, adiponectin, and inflammatory markers. Repeated measures ANOVA was used for intention-to-treat analysis. RESULTS: Retention was 90%. Mean change in LPIR (scale 0-100) differed by diet in a dose-dependent fashion: Low-Carb (-5.3; 95% CI: -9.2, -1.5), Moderate-Carb (-0.02; 95% CI: -4.1, 4.1), High-Carb (3.6; 95% CI: -0.6, 7.7), P = 0.009. Low-Carb also favorably affected lipoprotein(a) [-14.7% (95% CI: -19.5, -9.5), -2.1 (95% CI: -8.2, 4.3), and 0.2 (95% CI: -6.0, 6.8), respectively; P = 0.0005], triglycerides, HDL cholesterol, large/very large TRL-P, large HDL-P, and adiponectin. LDL cholesterol, LDL-P, and inflammatory markers did not differ by diet. CONCLUSIONS: A low-carbohydrate diet, high in saturated fat, improved insulin-resistant dyslipoproteinemia and lipoprotein(a), without adverse effect on LDL cholesterol. Carbohydrate restriction might lower CVD risk independently of body weight, a possibility that warrants study in major multicentered trials powered on hard outcomes. The registry is available through ClinicialTrials.gov: https://clinicaltrials.gov/ct2/show/NCT02068885. © The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition. | |
650 | 0 | 4 | |a adolescent |
650 | 0 | 4 | |a Adolescent |
650 | 0 | 4 | |a adult |
650 | 0 | 4 | |a Adult |
650 | 0 | 4 | |a aged |
650 | 0 | 4 | |a Aged |
650 | 0 | 4 | |a blood |
650 | 0 | 4 | |a body mass |
650 | 0 | 4 | |a Body Mass Index |
650 | 0 | 4 | |a body weight loss |
650 | 0 | 4 | |a cardiovascular disease risk factors |
650 | 0 | 4 | |a Cholesterol, HDL |
650 | 0 | 4 | |a Cholesterol, LDL |
650 | 0 | 4 | |a complication |
650 | 0 | 4 | |a controlled study |
650 | 0 | 4 | |a Diet, Carbohydrate-Restricted |
650 | 0 | 4 | |a Diet, Reducing |
650 | 0 | 4 | |a dietary trial |
650 | 0 | 4 | |a dyslipidemia |
650 | 0 | 4 | |a Dyslipidemias |
650 | 0 | 4 | |a female |
650 | 0 | 4 | |a Female |
650 | 0 | 4 | |a high density lipoprotein cholesterol |
650 | 0 | 4 | |a human |
650 | 0 | 4 | |a Humans |
650 | 0 | 4 | |a insulin |
650 | 0 | 4 | |a Insulin |
650 | 0 | 4 | |a insulin resistance |
650 | 0 | 4 | |a Insulin Resistance |
650 | 0 | 4 | |a intention to treat analysis |
650 | 0 | 4 | |a Intention to Treat Analysis |
650 | 0 | 4 | |a low calorie diet |
650 | 0 | 4 | |a low carbohydrate diet |
650 | 0 | 4 | |a low density lipoprotein cholesterol |
650 | 0 | 4 | |a low-carbohydrate diet |
650 | 0 | 4 | |a macronutrients |
650 | 0 | 4 | |a male |
650 | 0 | 4 | |a Male |
650 | 0 | 4 | |a middle aged |
650 | 0 | 4 | |a Middle Aged |
650 | 0 | 4 | |a obesity |
650 | 0 | 4 | |a obesity |
650 | 0 | 4 | |a Obesity |
650 | 0 | 4 | |a procedures |
650 | 0 | 4 | |a randomized controlled trial |
650 | 0 | 4 | |a saturated fat |
650 | 0 | 4 | |a treatment outcome |
650 | 0 | 4 | |a Treatment Outcome |
650 | 0 | 4 | |a triacylglycerol |
650 | 0 | 4 | |a Triglycerides |
650 | 0 | 4 | |a Weight Loss |
650 | 0 | 4 | |a young adult |
650 | 0 | 4 | |a Young Adult |
700 | 1 | 0 | |a Ebbeling, C.B. |e author |
700 | 1 | 0 | |a Greco, K.F. |e author |
700 | 1 | 0 | |a Johnson, A. |e author |
700 | 1 | 0 | |a Knapp, A. |e author |
700 | 1 | 0 | |a Ludwig, D.S. |e author |
700 | 1 | 0 | |a Ma, C. |e author |
700 | 1 | 0 | |a Mora, S. |e author |
700 | 1 | 0 | |a Wong, J.M.W. |e author |
773 | |t The American journal of clinical nutrition |